Fatty Acid Synthase Regulates Proliferation and Migration of Colorectal Cancer Cells Via HER2-PI3K/Akt Signaling Pathway

REFERENCES

• Warburg , O . 1956 . On the origin of cancer cells . Science , 123 : 309 – 314 .
   PubMed Web of Science ®Google Scholar
• Sugino , T , Baba , K , Hoshi , N , Aikawa , K Yamaguchi , O . 2011 . Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients . Med Mol Morphol , 44 : 146 – 150 .
   PubMed Web of Science ®Google Scholar
• Silva , S D , Cunha , I W , Younes , R N , Soares , F A Kowalski , L P . 2010 . ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas . Oral Dis , 16 : 774 – 780 .
   PubMed Web of Science ®Google Scholar
• Flavin , R , Peluso , S , Nguyen , P L and Loda , M . 2010 . Fatty acid synthase as a potential therapeutic target in cancer . Future Oncol , 6 : 551 – 562 .
   PubMed Web of Science ®Google Scholar
• Liu , J and Brown , R E . 2011 . Immunohistochemical expressions of fatty acid synthase and phosphorylated c-Met in thyroid carcinomas of follicular origin . Int J Clin Exp Pathol , 4 : 755 – 764 .
   PubMed Web of Science ®Google Scholar
• Uddin , S , Jehan , Z , Ahmed , M , Alyan , A Al-Dayel , F . 2011 . Overexpression of fatty acid synthase in Middle Eastern epithelial ovarian carcinoma activates AKT and Its inhibition potentiates cisplatin-induced apoptosis . Mol Med , 17 : 635 – 645 .
   PubMed Web of Science ®Google Scholar
• Wakil , S J . 1989 . Fatty acid synthase, a proficient multifunctional enzyme . Biochemistry , 28 : 4523 – 4530 .
   PubMed Web of Science ®Google Scholar
• Maier , T , Jenni , S and Ban , N . 2006 . Architecture of mammalian fatty acid synthase at 4.5 A resolution . Science , 311 : 1258 – 1262 .
   PubMed Web of Science ®Google Scholar
• Menendez , J A and Lupu , R . 2006 . Oncogenic properties of the endogenous fatty acid metabolism: molecular pathology of fatty acid synthase in cancer cells . Curr Opin Clin Nutr Metab Care , 9 : 346 – 357 .
   PubMed Web of Science ®Google Scholar
• Migita , T , Ruiz , S , Fornari , A , Fiorentino , M Priolo , C . 2009 . Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer . J Natl Cancer Inst , 101 : 519 – 532 .
   PubMed Web of Science ®Google Scholar
• Uddin , S , Hussain , A R , Ahmed , M , Abubaker , J Al-Sanea , N . 2009 . High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target . Am J Gastroenterol , 104 : 1790 – 1801 .
   PubMed Web of Science ®Google Scholar
• Ishimura , N , Amano , Y , Sanchez-Siles , A A , Fukuhara , H Takahashi , Y . 2011 . Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis . J Clin Gastroenterol , 45 : 665 – 672 .
   PubMed Web of Science ®Google Scholar
• Kumar-Sinha , C , Ignatoski , K W , Lippman , M E , Ethier , S P and Chinnaiyan , A M . 2003 . Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis . Cancer Res , 63 : 132 – 139 .
   PubMed Web of Science ®Google Scholar
• Jemal , A , Siegel , R , Ward , E , Hao , Y Xu , J . 2008 . Cancer statistics, 2008 . CA Cancer J Clin , 58 : 71 – 96 .
   PubMed Web of Science ®Google Scholar
• Huang , P L , Zhu , S N , Lu , S L , Dai , Z S and Jin , Y L . 2000 . Inhibitor of fatty acid synthase induced apoptosis in human colonic cancer cells . World J Gastroenterol , 6 : 295 – 297 .
   PubMed Web of Science ®Google Scholar
• Livak , K J and Schmittgen , T D . 2001 . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method . Methods , 25 : 402 – 408 .
   PubMed Web of Science ®Google Scholar
• Alo , P L , Amini , M , Piro , F , Pizzuti , L Sebastiani , V . 2007 . Immunohistochemical expression and prognostic significance of fatty acid synthase in pancreatic cancer . Anticancer Res , 27 : 2523 – 2527 .
   PubMed Web of Science ®Google Scholar
• Silva , S D , Cunha , I W , Rangel , A L , Jorge , J Zecchin , K G . 2008 . Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes . Virchows Arch , 453 : 57 – 67 .
   PubMed Web of Science ®Google Scholar
• da Silva , S D , Cunha , I W , Nishimoto , I N , Soares , F A Carraro , D M . 2009 . Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas . Oral Oncol , 45 : e134 – e139 .
   PubMed Web of Science ®Google Scholar
• Sehdev , A S , Kurman , R J , Kuhn , E and Shih , IeM . 2010 . Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase . Mod Pathol , 23 : 844 – 855 .
   PubMed Web of Science ®Google Scholar
• Zhang , D , Tai , L K , Wong , L L , Chiu , L L Sethi , S K . 2005 . Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer . Mol Cell Proteomics , 4 : 1686 – 1696 .
   PubMed Web of Science ®Google Scholar
• Menendez , J A , Oza , B P , Colomer , R and Lupu , R . 2005 . The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival . Int J Oncol , 26 : 1507 – 1515 .
   PubMed Web of Science ®Google Scholar
• Carey , L A . 2012 . Breast cancer: HER2-a good addiction . Nat Rev Clin Oncol , [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Menendez , J A , Vellon , L , Mehmi , I , Oza , B P Ropero , S . 2004 . Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells . Proc Natl Acad Sci USA , 101 : 10715 – 10720 .
   PubMed Web of Science ®Google Scholar
• Vazquez-Martin , A , Colomer , R , Brunet , J , Lupu , R and Menendez , J A . 2008 . Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells . Cell Prolif , 41 : 59 – 85 .
   PubMed Web of Science ®Google Scholar
• Bandyopadhyay , S , Pai , S K , Watabe , M , Gross , S C Hirota , S . 2005 . FAS expression inversely correlates with PTEN level in prostate cancer and a PI 3-kinase inhibitor synergizes with FAS siRNA to induce apoptosis . Oncogene , 24 : 5389 – 5395 .
   PubMed Web of Science ®Google Scholar
• Wang , H Q , Altomare , D A , Skele , K L , Poulikakos , P I Kuhajda , F P . 2005 . Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian cancer cells . Oncogene , 24 : 3574 – 3582 .
   PubMed Web of Science ®Google Scholar
• Chiang , C T , Way , T D , Tsai , S J and Lin , J K . 2007 . Diosgenin, a naturally occurring steroid, suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt, mTOR and JNK phosphorylation . FEBS Lett , 581 : 5735 – 5742 .
   PubMed Web of Science ®Google Scholar
• Toker , A and Cantley , L C . 1997 . Signalling through the lipid products of phosphoinositide-3-OH kinase . Nature , 387 : 673 – 676 .
   PubMed Web of Science ®Google Scholar
• Ghigo , A , Morello , F , Perino , A and Hirsch , E . 2012 . Phosphoinositide 3-kinases in health and disease . Subcell Biochem , 58 : 183 – 213 .
   PubMedGoogle Scholar
• Franke , T F , Kaplan , D R and Cantley , L C . 1997 . PI3K: downstream AKTion blocks apoptosis . Cell , 88 : 435 – 437 .
   PubMed Web of Science ®Google Scholar
• Dituri , F , Mazzocca , A , Giannelli , G and Antonaci , S . 2011 . PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors . Clin Dev Immunol , : 947858
   PubMedGoogle Scholar
• Kennedy , A L , Adams , P D and Morton , J P . 2011 . Ras, PI3K/Akt and senescence: Paradoxes provide clues for pancreatic cancer therapy . Small Gtpases , 2 : 264 – 267 .
   PubMedGoogle Scholar
• Hafner , C , Houben , R , Baeurle , A , Ritter , C Schrama , D . 2012 . Activation of the PI3K/AKT Pathway in Merkel Cell Carcinoma . PLoS One , 7 : e31255
   PubMed Web of Science ®Google Scholar
• Riggio , M , Polo , M L , Blaustein , M , Colman-Lerner , A Lüthy , I . 2012 . PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer . Carcinogenesis , 33 : 509 – 518 .
   PubMed Web of Science ®Google Scholar
• Yaguchi , S , Fukui , Y , Koshimizu , I , Yoshimi , H Matsuno , T . 2006 . Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor . J Natl Cancer Inst , 98 : 545 – 556 .
   PubMed Web of Science ®Google Scholar
• Kong , D , Okamura , M , Yoshimi , H and Yamori , T . 2009 . Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor . Eur J Cancer , 45 : 857 – 865 .
   PubMed Web of Science ®Google Scholar
• Kong , D and Yamori , T . 2007 . ZSTK474 is an ATP-competitive inhibitor of class I phosphatidylinositol 3 kinase isoforms . Cancer Sci , 98 : 1638 – 1642 .
   PubMed Web of Science ®Google Scholar
• Kong , D and Yamori , T . 2008 . Phosphatidylinositol 3-kinase inhibitors: promising drug candidates for cancer therapy . Cancer Sci , 99 : 1734 – 1740 .
   PubMed Web of Science ®Google Scholar
• Scotti , M L , Langenheim , J F , Tomblyn , S , Springs , A E and Chen , W Y . 2008 . Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells . Breast Cancer Res Treat , 111 : 241 – 250 .
   PubMed Web of Science ®Google Scholar
• Ozbay , T , Durden , D L , Liu , T , O’Regan , R M and Nahta , R . 2010 . In vitro evaluation of pan-PI3-kinase inhibitor SF1126 in trastuzumab-sensitive and trastuzumab-resistant HER2-over-expressing breast cancer cells . Cancer Chemother Pharmacol , 65 : 697 – 706 .
   PubMed Web of Science ®Google Scholar